Business Description
Inspire Medical Systems Inc
NAICS : 334510
SIC : 3845
ISIN : US4577301090
Description
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 16.23 | |||||
| Equity-to-Asset | 0.88 | |||||
| Debt-to-Equity | 0.04 | |||||
| Debt-to-EBITDA | 0.65 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 36.08 | |||||
| Beneish M-Score | -0.09 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 68.9 | |||||
| 3-Year EBITDA Growth Rate | 34.6 | |||||
| 3-Year EPS without NRI Growth Rate | 31 | |||||
| 3-Year Book Growth Rate | 31.7 | |||||
| Future 3-5Y Total Revenue Growth Rate | 21.31 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 57 | |||||
| 9-Day RSI | 53.31 | |||||
| 14-Day RSI | 50.93 | |||||
| 6-1 Month Momentum % | 24.13 | |||||
| 12-1 Month Momentum % | 38.01 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 7.84 | |||||
| Quick Ratio | 6.94 | |||||
| Cash Ratio | 5.53 | |||||
| Days Inventory | 149.38 | |||||
| Days Sales Outstanding | 38.95 | |||||
| Days Payable | 121.33 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3 | |||||
| Shareholder Yield % | -0.14 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 84.77 | |||||
| Operating Margin % | 1.79 | |||||
| Net Margin % | 4.37 | |||||
| FCF Margin % | 5.06 | |||||
| ROE % | 5.43 | |||||
| ROA % | 4.69 | |||||
| ROIC % | 6.33 | |||||
| ROC (Joel Greenblatt) % | 23.71 | |||||
| ROCE % | 5.35 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 180.15 | |||||
| Forward PE Ratio | 96.76 | |||||
| PE Ratio without NRI | 180.15 | |||||
| PEG Ratio | 17.49 | |||||
| PS Ratio | 7.67 | |||||
| PB Ratio | 8.29 | |||||
| Price-to-Tangible-Book | 8.29 | |||||
| Price-to-Free-Cash-Flow | 153.96 | |||||
| Price-to-Operating-Cash-Flow | 74.48 | |||||
| EV-to-EBIT | 159.2 | |||||
| EV-to-Forward-EBIT | 177.52 | |||||
| EV-to-EBITDA | 139.12 | |||||
| EV-to-Forward-EBITDA | 140.15 | |||||
| EV-to-Revenue | 7.13 | |||||
| EV-to-Forward-Revenue | 5.67 | |||||
| EV-to-FCF | 141.11 | |||||
| Price-to-Projected-FCF | 17.18 | |||||
| Price-to-Graham-Number | 8.15 | |||||
| Price-to-Net-Current-Asset-Value | 11.96 | |||||
| Price-to-Net-Cash | 18.55 | |||||
| Earnings Yield (Greenblatt) % | 0.63 | |||||
| FCF Yield % | 0.66 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:INSP
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Inspire Medical Systems Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 755.594 | ||
| EPS (TTM) ($) | 1.07 | ||
| Beta | 0.87 | ||
| Volatility % | 71.87 | ||
| 14-Day RSI | 50.93 | ||
| 14-Day ATR ($) | 8.953951 | ||
| 20-Day SMA ($) | 189.8985 | ||
| 12-1 Month Momentum % | 38.01 | ||
| 52-Week Range ($) | 123 - 257.4 | ||
| Shares Outstanding (Mil) | 29.97 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Inspire Medical Systems Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Inspire Medical Systems Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Inspire Medical Systems Inc Frequently Asked Questions
What is Inspire Medical Systems Inc(INSP)'s stock price today?
The current price of INSP is $192.76. The 52 week high of INSP is $257.40 and 52 week low is $123.00.
When is next earnings date of Inspire Medical Systems Inc(INSP)?
The next earnings date of Inspire Medical Systems Inc(INSP) is 2025-02-06 Est..
Does Inspire Medical Systems Inc(INSP) pay dividends? If so, how much?
Inspire Medical Systems Inc(INSP) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers